Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05598879 · ClinicalTrials.gov registry record
Global Cardio Oncology Registry
A clinical trial of Breast Cancer and Cardiovascular Diseases, sponsored by The Cleveland Clinic.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT05598879: Recruiting study of Breast Cancer and Cardiovascular Diseases, sponsored by The Cleveland Clinic.
NCT05598879 is a study of Breast Cancer and Cardiovascular Diseases that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 5,000 participants, above the 2,799-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (79% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05598879, a study of Breast Cancer and Cardiovascular Diseases, is actively recruiting participants, sponsored by The Cleveland Clinic.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
G-COR is the first Global Prospective Cardio-Oncology Registry. It is a multinational, multicenter prospective observational cohort registry, with the goal of collecting clinical, laboratory, imaging, demographic, and socioeconomic data to identify risk factors associated with increased incidence of cancer therapy related cardiovascular toxicity (CTR-CVT) in different settings and to derive and validate risk scores for cardio oncology patients treated in different geographic locations throughout the world.
Primary Outcome
Any new cardiac event occurring during or after cancer treatment
Conditions Studied
Interventions
- OTHER anonymized data collection during programmed surveillance clinical follow up
Study Locations (1)
Florida
- Cleveland Clinic Florida - Weston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2022-07-01 |
| Est. Completion | 2027-07-01 |
What NCT05598879 shows while recruiting
NCT05598879 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 2,799-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (79% higher).
The record links to 5 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which anonymized data collection during programmed surveillance clinical follow up is the first listed.
NCT05598879 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05598879 about?
NCT05598879 is a clinical study titled "Global Cardio Oncology Registry". G-COR is the first Global Prospective Cardio-Oncology Registry. It is a multinational, multicenter prospective observational cohort registry, with the goal of collecting clinical, laboratory, imaging, demographic, and socioeconomic data to identify risk factors associated with increased incidence of...
What is the current status of trial NCT05598879?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2022-07-01. Estimated completion is 2027-07-01.
What conditions does trial NCT05598879 study?
This clinical trial studies the following conditions: Breast Cancer, Cardiovascular Diseases, Hematologic Malignancy, Cardiotoxicity, Immune Checkpoint Inhibitor-Related Myocarditis.
What interventions are being tested in trial NCT05598879?
The interventions under investigation include: anonymized data collection during programmed surveillance clinical follow up (OTHER).
Who is sponsoring clinical trial NCT05598879?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05598879 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05598879's enrollment target sits among peer trials
5,000 28th of 1224 higher than 1,195 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI